SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
497Going back a little bit more than a year (until November 30, 2001 to be precise)Icebrg-2/20/2003
496Today's Abgenix conference call. This must be the most embarrassing confereIcebrg-2/20/2003
495>>Wonder what the Eos/MEDX agreements have to say about change of ownershiIcebrg-2/4/2003
494Wonder what the Eos/MEDX agreements have to say about change of ownership ? Counigel bates-2/4/2003
493Protein Design Labs to Acquire Eos Biotechnology, Inc. Message 18534862 Eos waIcebrg-2/4/2003
492Looks like MEDX is losing another committed partner to a target/antibody marriagnigel bates-2/4/2003
491Nigel I thought so to, until I realised that they are both supposed to supply tIcebrg-2/3/2003
490I think the funding contribution is as important as the targets. (nb they also snigel bates-2/3/2003
489Abgenix and Chugai Collaborate to Develop and Manufacture Antibody Therapeutics Icebrg-2/3/2003
488CRXL out of the mAB business Message 18495186nigel bates-1/27/2003
487MorphoSys, Lonza Biologics In 5-Year Antibody Agreement Monday January 27, 1:58 Icebrg-1/27/2003
486(Domantis; formerly Diversys) - parking... ABBOTT PARK, IL, USA and Cambridge, nigel bates-1/25/2003
485PNNL, MIT Build Library of One Billion Antibodies By a GenomeWeb staff reporternigel bates-1/25/2003
484NEWTON UPPER FALLS, Mass., Jan 21 /PRNewswire/ -- The market for monoclonal antinigel bates-1/21/2003
483EXTON, Pa., Jan. 21 /PRNewswire/ -- Morphotek Inc. announced today that it has snigel bates-1/21/2003
482<i>"This agreement with Medarex represents a significant milestone innigel bates-1/20/2003
481>>Abbott deal with MEDX >> I was just about to paste it here. :-) BIcebrg-1/20/2003
480Abbott deal with MEDX - Message 18465607nigel bates-1/20/2003
479They probably want several hundred dollars and an industry connection to attend.tuck-1/17/2003
478One for Tuck ? SAN DIEGO, Jan. 17 /PRNewswire/ -- The first Antibody conferencenigel bates-1/17/2003
477Nigel, Nice find. I would expect folks would be interested in licensing that ttuck-1/16/2003
476Lerner heads the SAB at Epicyte, and Epicyte is working on a topical for herpes.scaram(o)uche-1/16/2003
475Producing Human Antibodies in Algae 1/15/2003 -- A group of scientists at The Snigel bates-1/16/2003
474Further CAT / DYAX agreement - Message 18405493 Royalties now in one directionnigel bates-1/6/2003
473HuMAb related post(s)... Regarding new data from Applied Molecular Evolution rescott_jiminez-1/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News